search
Back to results

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

Primary Purpose

Metastatic Sarcoma, Sarcoma

Status
Not yet recruiting
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Assessment
Questionnaire Administration
Interview
Electronic Health Record Review
Sponsored by
Fred Hutchinson Cancer Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional supportive care trial for Metastatic Sarcoma

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria: PATIENTS: Age 18 years of age or older. PATIENTS: English speaking PATIENTS: Able to provide informed consent PATIENTS: Have access to a computer or other device to fill out the online checklist PATIENTS: Have had either limb salvage or amputation surgery for sarcoma within the last 6 months OR have metastatic (stage IV) sarcoma and are in active treatment. CAREGIVERS: Age 18 years of age or older CAREGIVERS: English speaking CAREGIVERS: Able to provide informed consent CAREGIVERS: Have access to a computer or other device to fill out the online checklist CAREGIVERS: The person (family member or friend) whom the patient indicates being an informal caregiver

Sites / Locations

  • Fred Hutch/University of Washington Cancer Consortium

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Supportive Care (advanced care planning checklist)

Arm Description

FIELD TEST: Participants complete the Advance Care Planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants medical records are also reviewed.

Outcomes

Primary Outcome Measures

Feasibility, as measured by the number of subjects accrued to the study
The number of participants accrued during the recruitment period.
Feasibility, as measured by the number of subjects to complete the intervention
The number of participants to complete the intervention.
Acceptability of the intervention: Acceptability E-Scale
The Acceptability E-Scale is a 6-item scale, scored on a 5-point Likert scale (e.g., 1=very difficult; 5= very easy), with previously demonstrated good internal consistency (Cronbach's alpha=.76), with higher values indicating higher levels of acceptability.
Usability: System Usability Scale (SUS)
Usability of the ACP Mobility Checklist will be assessed among patients using the System Usability Scale (SUS). The SUS is a 10-item scale, scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree), with higher values indicating higher levels of usability.
Acceptability: Satisfaction with the intervention
Satisfaction with the intervention will be assessed with a single, 10-point Likert scale item assessing how satisfied participants are with the intervention (1= not at all satisfied, 10 = extremely satisfied). Higher values indicate higher ratings of satisfaction.

Secondary Outcome Measures

Change in planning for mobility needs
Will be measured by asking participants seven items about what mobility needs they have planned for (e.g., assistance with home environment, toileting, dressing, etc.) (yes/no). Total scores can range from 0 to 7, with higher values indicating higher rates of understanding and awareness.
Change in functional status
Functional status will be measured using the PROMIS Cancer Function Brief, which is a validated 12-item scale scored on a 5-point Likert scale, with higher scores indicating better functioning.
Change in patients' engagement in clinical conversations (present/absent) with specialist providers
Engagement in clinical conversations (present/absent) with providers will be measured with four questions asking patients if they have had an interaction or consult with a physical therapist, occupational therapist, speech language pathologist, and/or rehabilitation physician (yes/no). Total scores can range from 0 to 4, with higher values indicating higher rates of engagement in clinical conversations with specialist providers.
Change in discussion of advance directives
This will be measured using our previously utilized 8-item measure of discussing end-of-life care, living will, healthcare proxy, and do-not-resuscitate orders with family and doctor (all yes/no questions).
Change in completion of advance directives
This will be assessed by asking patients whether they have completed a Do Not Resuscitate order (DNR), living will, or identified a Health Care Proxy (HCP). All yes/no questions.

Full Information

First Posted
April 17, 2023
Last Updated
October 9, 2023
Sponsor
Fred Hutchinson Cancer Center
search

1. Study Identification

Unique Protocol Identification Number
NCT05835154
Brief Title
A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma
Official Title
Improving Advance Care Planning Around Mobility Needs Among Patients With Sarcoma
Study Type
Interventional

2. Study Status

Record Verification Date
October 2023
Overall Recruitment Status
Not yet recruiting
Study Start Date
January 2024 (Anticipated)
Primary Completion Date
June 30, 2024 (Anticipated)
Study Completion Date
June 30, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fred Hutchinson Cancer Center

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This trial tests how well the advanced care planning around mobility needs checklist tool works to assess future mobility needs in patients with sarcoma. Gathering information about sarcoma patients that have had surgery to either save or remove a limb may help doctors learn more about a patient's mobility needs. Using an advance care planning mobility needs assessment may help improve the quality of life in patients with sarcoma by helping them plan for their future mobility needs.
Detailed Description
OUTLINE: FIELD TEST: Participants complete the advance care planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants' medical records are also reviewed.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Metastatic Sarcoma, Sarcoma

7. Study Design

Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
20 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Supportive Care (advanced care planning checklist)
Arm Type
Experimental
Arm Description
FIELD TEST: Participants complete the Advance Care Planning (ACP) Mobility Checklist on study. Participants complete questionnaires at baseline and after completing the checklist intervention and undergo interview on study. Participants medical records are also reviewed.
Intervention Type
Behavioral
Intervention Name(s)
Assessment
Other Intervention Name(s)
Assess
Intervention Description
Complete checklist
Intervention Type
Other
Intervention Name(s)
Questionnaire Administration
Intervention Description
Complete questionnaires
Intervention Type
Other
Intervention Name(s)
Interview
Intervention Description
Undergo semi-structured feedback interview
Intervention Type
Other
Intervention Name(s)
Electronic Health Record Review
Intervention Description
Review of medical records
Primary Outcome Measure Information:
Title
Feasibility, as measured by the number of subjects accrued to the study
Description
The number of participants accrued during the recruitment period.
Time Frame
At enrollment
Title
Feasibility, as measured by the number of subjects to complete the intervention
Description
The number of participants to complete the intervention.
Time Frame
Through study completion, up to 4 weeks
Title
Acceptability of the intervention: Acceptability E-Scale
Description
The Acceptability E-Scale is a 6-item scale, scored on a 5-point Likert scale (e.g., 1=very difficult; 5= very easy), with previously demonstrated good internal consistency (Cronbach's alpha=.76), with higher values indicating higher levels of acceptability.
Time Frame
After completion of intervention (+ 1 week)
Title
Usability: System Usability Scale (SUS)
Description
Usability of the ACP Mobility Checklist will be assessed among patients using the System Usability Scale (SUS). The SUS is a 10-item scale, scored on a 5-point Likert scale (1=strongly disagree; 5=strongly agree), with higher values indicating higher levels of usability.
Time Frame
After completion of intervention (+ 1 week)
Title
Acceptability: Satisfaction with the intervention
Description
Satisfaction with the intervention will be assessed with a single, 10-point Likert scale item assessing how satisfied participants are with the intervention (1= not at all satisfied, 10 = extremely satisfied). Higher values indicate higher ratings of satisfaction.
Time Frame
After completion of intervention (+ 1 week)
Secondary Outcome Measure Information:
Title
Change in planning for mobility needs
Description
Will be measured by asking participants seven items about what mobility needs they have planned for (e.g., assistance with home environment, toileting, dressing, etc.) (yes/no). Total scores can range from 0 to 7, with higher values indicating higher rates of understanding and awareness.
Time Frame
From baseline to after completion of intervention (+ 1 week)
Title
Change in functional status
Description
Functional status will be measured using the PROMIS Cancer Function Brief, which is a validated 12-item scale scored on a 5-point Likert scale, with higher scores indicating better functioning.
Time Frame
From baseline to after completion of intervention (+ 1 week)
Title
Change in patients' engagement in clinical conversations (present/absent) with specialist providers
Description
Engagement in clinical conversations (present/absent) with providers will be measured with four questions asking patients if they have had an interaction or consult with a physical therapist, occupational therapist, speech language pathologist, and/or rehabilitation physician (yes/no). Total scores can range from 0 to 4, with higher values indicating higher rates of engagement in clinical conversations with specialist providers.
Time Frame
From baseline to after completion of intervention (+ 1 week)
Title
Change in discussion of advance directives
Description
This will be measured using our previously utilized 8-item measure of discussing end-of-life care, living will, healthcare proxy, and do-not-resuscitate orders with family and doctor (all yes/no questions).
Time Frame
From baseline to after completion of intervention (+ 1 week)
Title
Change in completion of advance directives
Description
This will be assessed by asking patients whether they have completed a Do Not Resuscitate order (DNR), living will, or identified a Health Care Proxy (HCP). All yes/no questions.
Time Frame
From baseline to after completion of intervention (+ 1 week)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: PATIENTS: Age 18 years of age or older. PATIENTS: English speaking PATIENTS: Able to provide informed consent PATIENTS: Have access to a computer or other device to fill out the online checklist PATIENTS: Have had either limb salvage or amputation surgery for sarcoma within the last 6 months OR have metastatic (stage IV) sarcoma and are in active treatment. CAREGIVERS: Age 18 years of age or older CAREGIVERS: English speaking CAREGIVERS: Able to provide informed consent CAREGIVERS: Have access to a computer or other device to fill out the online checklist CAREGIVERS: The person (family member or friend) whom the patient indicates being an informal caregiver
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Megan Shen
Phone
206-667-4172
Email
mshen2@fredhutch.org
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Megan Shen
Organizational Affiliation
Fred Hutch/University of Washington Cancer Consortium
Official's Role
Principal Investigator
Facility Information:
Facility Name
Fred Hutch/University of Washington Cancer Consortium
City
Seattle
State/Province
Washington
ZIP/Postal Code
98109
Country
United States
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Megan Shen
Phone
206-667-4172
Email
mshen2@fredhutch.org
First Name & Middle Initial & Last Name & Degree
Megan Shen

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

A Checklist (Advanced Care Planning) for The Assessment of Mobility Needs in Patients With Sarcoma

We'll reach out to this number within 24 hrs